Xultophy and Soliqua Will Be the First Basal Insulin/GLP-1 Agonist Combos

Xultophy (ZUL-toh-fye) and Soliqua (soh-LEE-kwa) will be two new once-daily injectables for type 2 diabetes....

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login